Vetsys Pharmaceutical
Vetsys Pharmaceutical
As a leading Sustained-release Boluses Manufacturer & Exporter in Serbia, we recognize that the Serbian agricultural sector is undergoing a massive technological transformation. From the fertile plains of Vojvodina to the mountainous livestock regions in Central Serbia, the demand for high-efficiency veterinary medicine is at an all-time high. The Serbian livestock industry, particularly in cattle and sheep farming, requires advanced bolus technology to ensure long-term health management without the labor-intensive need for daily dosing.
Our sustained-release technology (SRT) is designed to meet the rigorous demands of EU veterinary standards, which Serbia is increasingly adopting. By providing a steady release of active ingredients over weeks or months, our boluses help Serbian farmers combat local environmental challenges, such as mineral deficiencies in Balkan soil and seasonal parasitic pressures.
The industrial trend in Serbia is shifting toward precision animal husbandry. As labor costs rise in Eastern Europe, the "one-and-done" philosophy of bolus administration becomes a critical economic advantage. Modern Serbian exporters of meat and dairy are also under pressure to reduce antibiotic residues. Our sustained-release boluses allow for precise, sub-therapeutic or therapeutic levels that minimize the risk of "dosage spikes," ensuring better animal welfare and cleaner food chains.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is more than just a manufacturer; we are a technological hub for animal health innovation. With a registered capital of 30 million RMB, we have built a world-class production infrastructure. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in strict compliance with Good Manufacturing Practices (GMP). This commitment to quality has allowed us to grow into one of the top animal pharmaceutical producers, achieving annual sales of over USD 20 million by 2015. For the Serbian market, this means every bolus or premix exported meets international safety and efficacy benchmarks.
What sets Vetsys apart in the Serbian and global market is our emphasis on scientific depth. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health, specifically tailored for diverse climates and industrial conditions.
Quality is the cornerstone of our operations. Vetsys has developed a comprehensive quality management system to oversee every aspect of production. As part of our long-term vision, we are committed to sustainability, investing in green technologies to minimize environmental impact. We are actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets through partnerships and research collaborations.
